CORT

Corcept Therapeutics Inc.
Data: 2026-02-02
$40.71
Price
2.06%
Change
$117.33
52W High
$32.9906
52W Low

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Quick Stats
Feb 02, 2026

57.3

AI Score

HOLD

0.84

Volume Ratio

Feb 25, 2026

Next Earnings

15

+ve Days (30d)

15

-ve Days (30d)

CORT Stock Summary

Last updated Feb 02, 2026

CORT is currently trading at $40.71, positioned below its 200-day moving average of $70.76, suggesting bearish momentum. The stock has a 52-week range of $32.9906 to $117.33.

Technical Analysis: The 50-day moving average stands at $62.81, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 37.572, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.034, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CORT at 57.3/100 with a HOLD recommendation.

CORT (Corcept Therapeutics Inc.) Indicators

Last updated Feb 02, 2026

Indicator Value
RSI(14) 37.572
CMF (20) -0.034
ROC (10) 17.219
ADX (14) 42.856
Indicator Value
MACD (12,26,9) -5.268
AROONOSC (14) 42.857
WILLAMS %R (14) -47.888
MFI (14) 62.959
CORT Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CORT Price vs Max Options Open Interest
CORT Max Change In Options Open Interest

CORT Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CORT Daily Out of Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CORT Daily In the Money Options - Sort by Max open Interest (near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CORT Most Active Options by Volume(near term)

2nd February 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Corcept Therapeutics Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

CORT Moving Averages Analysis

CORT (Corcept Therapeutics Inc.) Simple Moving Averages

Moving Averages are last updated Feb 02, 2026

Days MA
10 41.98
20 39.12
30 50.18
50 62.81
100 70.22
200 70.76

CORT Fundamental Analysis

P/E (Forward) 85.4701
P/E (Trailing) 51.1154
Market Cap ($) 4.2 billion
Earnings/Share ($) 0.78
Net Proft Margin (%) 0.1432
Dividend/Share ($) --
EPS Estimate Current Year ($) 0.931
EPS Estimate Next Year ($) 0.732
WallStreet Target Price ($) 94.2
Most Recent Quarter